Corona's vaccine successful in the first phase, the strength to fight the increasing disease in patients

A relief news is coming to the people amidst the outbreak of Corona's epidemic. American drug maker Moderna is preparing for the last stage trial of the Coronavirus vaccine. According to the company, this trial can be started on July 27. Moderna said that it would conduct trials of the vaccine at 87 locations in the US. 30 thousand people will be included for the test. People involved in the trial will be given a dose of 100 micrograms of the potential vaccine on the first day, followed by a second dose 29 days later. It is believed that after the third phase of the trial is successful, the company can make a big announcement.

Corona's vaccine successful in the first phase, the strength to fight the increasing disease in patients

American vaccine was successful in first test

American company Moderna's Coronavirus vaccine was a complete success in its first trial. The study, published in the New England Journal of Medicine, says that the first test of this vaccine on 45 healthy people has had very good results. This vaccine developed antibodies to rust from the coronavirus within each individual. Another good thing about Moderna's vaccine is that it did not have such a significant side effect, because of which the trial of vaccine should be stopped. If antibodies are produced in initial testing, it is considered a major success, but this does not mean that this vaccine will be effective in eradicating the coronavirus. This first test included 45 such people who were healthy and their age was between 18 and 55 years.

Trial will be done in the most corona affected areas

The trial of this potential vaccine will be done in 30 other states of the country besides the capital, Washington DC. More than half of the locations selected for vaccine trials are located in Texas, California, Florida, Georgia, Arizona, and North and South Carolina, the most affected by the coronavirus.

In 13 vaccine clinical trial phase worldwide

There are currently more than 120 participants working on the coronavirus vaccine in the world at present. However, 13 of these vaccines have reached the clinical trial phase. The maximum of these is in China's vaccine human trial. Let us know that 5 in China, 2 in UK, 3 in US, Russia in Australia and Germany 1-1 vaccine are in clinical trial phase.

Corona's vaccine successful in the first phase, the strength to fight the increasing disease in patients

Countries that are preparing Corona's vaccine are making contact with India

Countries producing Coronavirus vaccines and their companies are turning to India for its production. According to ICMR Director General Dr. Balram Bhargava, Corona's, India, which supplies 60 percent of the total vaccine worldwide, has a central role in the vaccine supply chain. Along with this, giving information about the commencement of human trials of two indigenous vaccines, he said that their path will not be allowed to be delayed for even a day at the administrative level. Indicating vaccine as the last option in preventing corona's infection, Dr. Balaram Bhargava said that all the countries of the world are fast tracking the process of vaccine preparation and are getting success in it. He said that Russia has even completed the vaccine trial. Similarly, China, America, Britain and other countries are busy preparing vaccines as soon as possible.

Human trial of two vaccines started in India

Human trials of biotech and Zydus Cadila vaccine have also started in India. Dr. Balram Bhargava said that it is our moral responsibility to fast-track the indigenous vaccine and make it available to the common people at the earliest. He assured that the preparation of indigenous vaccine will not be allowed to be delayed by even a day due to administrative reasons. Doctor Bhargava, who talked about making the indigenous vaccine available to the general public till August 15, has not given any time limit for this. But he assured that the corona vaccine produced in the world will be available to people in India as well.

Any vaccine produced anywhere in the world will have to depend on India for production

60 percent of the world's vaccine is made in India and that is why today 'all the world's vaccine makers are in touch with India'. He said that any vaccine produced anywhere in the world, he would have to depend on India for production. It is to be noted that Oxford University has also tied up with the Indian company Serum Institute for the production of its upcoming vaccine.

Corona's vaccine successful in the first phase, the strength to fight the increasing disease in patients

Human trials of two Covid-19 vaccine started in India too

The practice of overcoming coronaviruses has also intensified in India. India and China are the two largest countries in the world, who make the most of vaccine production. India is considered the world's pharmacy. A country as big as the US depends on 60 per cent of India's medicines. To overcome coronavirus, India has manufactured two vaccines, whose human trials have also been started.

The Drug Controller General of India (DCGI) has given permission for first and second stage human trials of two vaccines. One of these vaccines has been developed by Bharat Biotech International Limited in association with ICMR, while the other vaccine has been developed by Zydus Cadila Healthcare Limited.

Indian Council of Medical Research (ICMR) said on Tuesday that human trials of covid-19 vaccine have started in the country. About one thousand volunteers are participating in the trial of two vaccines developed in the country.

ICMR Director General Dr. Balaram Bhargava said that it is the 'moral obligation' of the country to speed up the vaccine development process to break the link of coronavirus spread. Bhargava said in a press briefing that there are two Indian vaccines that have been successfully studied in mice and rabbits and this data was submitted to DCGI after which both vaccines were allowed for early stage human trials earlier this month. Bhargava recently wrote a letter envisaging bringing the covid-19 vaccine by August 15, which many experts do not agree with.

Corona's vaccine successful in the first phase, the strength to fight the increasing disease in patients

He said that whether polio vaccine or measles, 60 percent of the rubella vaccines are still produced in India and given to international agencies for supply to the world, thus making it an important aspect for India that Speed ​​up vaccine development and work together to develop these vaccines for the whole world.